|
Neuroprotectors
Citations 441-450 of 537 total displayed.
|
Past content
(since Jan 1999):
|
- Original Contributions
Neuroprotection by Selective Nitric Oxide Synthase Inhibition at 24 Hours After Perinatal Hypoxia-Ischemia
- Cacha Peeters-Scholte, Johanna Koster, Wouter Veldhuis, Evelyn van den Tweel, Changlian Zhu, Nicole Kops, Klas Blomgren, Dop Bär, Sylvia van Buul-Offers, Hendrik Hagberg, Klaas Nicolay, Frank van Bel, and Floris Groenendaal
Stroke 2002;33:2304-2310, doi:10.1161/01.STR.0000028343.25901.09
[Abstract]
[Full text]
- Comments, Opinions, and Reviews
Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions
- David J. Gladstone, Sandra E. Black, and Antoine M. Hakim
Stroke 2002;33:2123-2136, doi:10.1161/01.STR.0000025518.34157.51
[Abstract]
[Full text]
- Original Contributions
Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular Dementia: A Randomized, Placebo-Controlled Trial (MMM 300)
- Jean-Marc Orgogozo, Anne-Sophie Rigaud, Albrecht Stöffler, Hans-Jorgen Möbius, and Françoise Forette
Stroke 2002;33:1834-1839, doi:10.1161/01.STR.0000020094.08790.49
[Abstract]
[Full text]
- Original Contributions
Neuroprotective Effect of Delayed Moderate Hypothermia After Focal Cerebral Ischemia: An MRI Study
- R. Kollmar, W.R. Schäbitz, S. Heiland, D. Georgiadis, P.D. Schellinger, J. Bardutzky, and S. Schwab
Stroke 2002;33:1899-1904, doi:10.1161/01.STR.0000019603.29818.9C
[Abstract]
[Full text]
- Original Contributions
Expression of Human Apolipoprotein E Downregulates Amyloid Precursor Protein–Induced Ischemic Susceptibility
- Milla Koistinaho, Mikko I. Kettunen, David M. Holtzman, Risto A. Kauppinen, Linda S. Higgins, and Jari Koistinaho
Stroke 2002;33:1905-1910, doi:10.1161/01.STR.0000020124.61998.BC
[Abstract]
[Full text]
- Original Contributions
Heterogeneity of Stroke Pathophysiology and Neuroprotective Clinical Trial Design
- Keith W. Muir
Stroke 2002;33:1545-1550, doi:10.1161/01.STR.0000018684.86293.AB
[Abstract]
[Full text]
- Original Contributions
Effects of the Spin Trap Agent Disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide (Generic NXY-059) on Intracerebral Hemorrhage in a Rabbit Large Clot Embolic Stroke Model: Combination Studies With Tissue Plasminogen Activator
- Paul A. Lapchak, Dalia M. Araujo, Donghuan Song, Jiandong Wei, Robert Purdy, and Justin A. Zivin
Stroke 2002;33:1665-1670, doi:10.1161/01.STR.0000017145.22806.AA
[Abstract]
[Full text]
- Original Contributions
Neuroprotection and P450 2C11 Upregulation After Experimental Transient Ischemic Attack
- Nabil J. Alkayed, Toru Goyagi, Hung-Dong Joh, Judith Klaus, David R. Harder, Richard J. Traystman, and Patricia D. Hurn
Stroke 2002;33:1677-1684, doi:10.1161/01.STR.0000016332.37292.59
[Abstract]
[Full text]
- Original Contributions
Malignant Infarction in Cats After Prolonged Middle Cerebral Artery Occlusion: Glutamate Elevation Related to Decrease of Cerebral Perfusion Pressure
- Shingo Toyota, Rudolf Graf, Mario Valentino, Toshiki Yoshimine, and Wolf-Dieter Heiss
Stroke 2002;33:1383-1391, doi:10.1161/01.STR.0000015557.18508.DD
[Abstract]
[Full text]
- Original Contributions
Neuroprotective Effects of the Spin Trap Agent Disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-Oxide (Generic NXY-059) in a Rabbit Small Clot Embolic Stroke Model: Combination Studies With the Thrombolytic Tissue Plasminogen Activator
- Paul A. Lapchak, Dalia M. Araujo, Donghuan Song, Jiandong Wei, and Justin A. Zivin
Stroke 2002;33:1411-1415, doi:10.1161/01.STR.0000015346.00054.8B
[Abstract]
[Full text]
|
|
